08/09/2022
Denise Nemeth, MPAS, CWS, PA-C; Jayesh B. Shah, MD, MSc, UHM, ABPM, CWSP, FAPWCA
Idiopathic sudden sensorineural hearing loss and central retinal artery occlusion were both approved as indications by the UHMS and the ACHM in 2011, but the FDA only recently approved these two indications in 2021.
Idiopathic sudden sensorineural hearing loss and central retinal artery occlusion were both approved as indications by the UHMS and the ACHM in 2011, but the FDA only recently approved these two indications in 2021.
Idiopathic sudden sensorineural...